mewburn-logo-white mewburn-logo
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
    • 8 Bishopsgate
    • Residencies
  • en
  • zh-hans
  • germany
  • ja
  • ko
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
    • 8 Bishopsgate
    • Residencies
  • All topics
  • Forward
  • Artificial Intelligence
  • Battery Technologies
  • Bioinformatics
  • Brexit
  • Chemistry
  • Commercial Advice
  • Community
  • COVID-19
  • Designs
  • Energy Storage
  • Engineering
  • EU Unitary Patent / Unified Patent Court
  • FemTech
  • Future Food Tech
  • Future Mobility
  • Graphene & 2D Materials
  • Green Tech
  • ICT
  • Life Sciences
  • Litigation
  • Marine & Ocean Engineering
  • Materials
  • MedTech
  • Microbiome
  • Nature based materials
  • Nuclear
  • On-Demand
  • Oppositions
  • Patents
  • Pharmaceuticals
  • Plants
  • Polymers
  • Polymer recycling
  • Precision Medicine
  • Quantum Computing
  • SME
  • Software
  • Space Tech
  • Synthetic Biology
  • Trade Marks
The major players in the SEP landscape in Europe
Tom Furnival - February 14, 2024

The major players in the SEP landscape in Europe

Next in our series of blogs, we have investigated the major players in the SEP landscape in Europe.

How does declaring a patent or application as “essential to a standard” affect the pre-grant experience of an application? – Part 3
Tom Furnival - December 19, 2023

How does declaring a patent or application as “essential to a standard” affect the pre-grant experience of an application? – Part 3

This article continues our series of blogs investigating whether or not declaring your patent or ...

How does declaring a patent or application as “essential to a standard” affect the pre-grant experience of an application? – Part 2
Tom Furnival - September 20, 2023

How does declaring a patent or application as “essential to a standard” affect the pre-grant experience of an application? – Part 2

This article is the latest in a series of blogs exploring whether declaring your patent or ...

How does declaring a patent or application as “essential to a standard” affect the pre-grant experience of an application?
Tom Furnival - August 7, 2023

How does declaring a patent or application as “essential to a standard” affect the pre-grant experience of an application?

This article is the latest in a series of blogs exploring whether declaring your patent or ...

Standards, SEPs, and FRAND agreements - an overview
Charlotte Lynch - August 16, 2022

Standards, SEPs, and FRAND agreements - an overview

The terms “standards,” “SEPs,” and “FRAND agreements,” are increasingly being mentioned in the ...

YouGov survey finds that nearly a quarter of businesses have been a victim of cybersquatting
Andy King - June 28, 2021

YouGov survey finds that nearly a quarter of businesses have been a victim of cybersquatting

A recent survey conducted by Mewburn Ellis, in conjunction with YouGov, revealed that nearly a ...

Ericsson accuses Samsung of un-FRAND-ly patent negotiations
Tom Furnival - December 17, 2020

Ericsson accuses Samsung of un-FRAND-ly patent negotiations

Following on from Unwired Planet v Huawei, Ericsson have launched a complaint in the US District ...

Düsseldorf Regional Court refers Nokia vs. Daimler licensing dispute to CJEU
Christoph Moeller - December 1, 2020

Düsseldorf Regional Court refers Nokia vs. Daimler licensing dispute to CJEU

As anticipated, the Düsseldorf Regional Court, in its decision Nokia ./. Daimler (4c O 17/19) ...

Unwired Planet v Huawei – the Supreme Court’s FRAND(ly) judgement
Tom Furnival - August 26, 2020

Unwired Planet v Huawei – the Supreme Court’s FRAND(ly) judgement

Published Wednesday 26th August 2020, the Supreme Court has handed down their long anticipated ...

Nokia vs. Daimler - FRAND defence does not apply
Christoph Moeller - August 18, 2020

Nokia vs. Daimler - FRAND defence does not apply

Breaking News in Nokia vs. Daimler (2 O 34/19) - (FRAND/SEP case)

Landmark judgement in German FRAND case Sisvel vs. Haier
Christoph Moeller - July 15, 2020

Landmark judgement in German FRAND case Sisvel vs. Haier

On May 5, 2020, the Cartel Senate of the German Federal Supreme Court (BGH) held the oral hearing ...

FRAND Licensing of SEPs in the age of connected cars
Christoph Moeller - October 26, 2019

FRAND Licensing of SEPs in the age of connected cars

Cars are developing more and more into computerized mobile platforms. They relieve the driver of ...

Future mobility: the new direction of transport
Christoph Moeller - December 11, 2018

Future mobility: the new direction of transport

Massive social, economic and technology trends are converging to change mobility - how we move ...

More

  • Slavery Act
  • Legal Notices
  • Terms and Conditions
  • Privacy
  • Forward Community Programme
  • Client Login
  • Join Mewburn Ellis

Follow us

Subscribe

Sign up to Forward: news, insights and features from Mewburn Ellis

Contact

  • mail@mewburn.com
  • London:

    +44 (0)20 7776 5300
  • Bristol:

    +44 (0)117 945 1234
  • Cambridge:

    +44 (0)1223 420383
  • Manchester:

    +44 (0)161 2477 722
  • Munich:

    +49 (0)89 244 459800

Copyright © 2025 Mewburn Ellis. All rights reserved. Terms and Conditions & Online Privacy